A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot
The panel voted 7-2 that the benefits outweighed the risks when using the Guardant Health's Shield test for colon “The advisory committee's strong support for the approval of Shield reinforces the crucial role that a blood test option can have in improving screening rates for those at average risk,” Guardant co-CEO AmirAli Talasaz, said in a company news release announcing the panel vote.early, there are notable barriers that can deter average-risk Americans from completing existing screening methods," Talasaz added.
Colorectal cancer is the cause of many cancer deaths. Learn about the warning signs, symptoms, screening process, stages, and treatment related to colorectal cancer.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Medscape - 🏆 386. / 55 Read more »
Source: ABC - 🏆 471. / 51 Read more »
Source: NBCNewsHealth - 🏆 707. / 51 Read more »